Masaru Oshita

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

Y. Soo, G. Yancopoulos, D. Weinreich, 2022, International Journal of Infectious Diseases.

Retrospective Analysis of Emergency Department Ultrasound for Acute Appendicitis

M. Langdorf, J. Fox, A. Zlidenny, 2007, The California journal of emergency medicine.